title: [Breast cancer].
abstract: Almost all breast cancer patients are treated with chemotherapy, hormone therapy, molecular targeted therapy, radiotherapy, and surgery alone or in combination. It is reasonable and standard to choose a combination according to clinical practice guidelines. One of the objectives of clinical practice guidelines is to standardize medical care and provide equal quality of care for patients wherever they live in Japan. Recently, many clinical trials have been conducted internationally. Therefore, it is necessary to standardize medical care from an international viewpoint. In this paper, the breast cancer clinical practice guideline developed by the Japanese Breast Cancer Society was compared with other guidelines which have been already developed and are frequently utilized all over the world as well as in Japan.
authors.affiliation: Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Kanagawa, Japan.
authors.forename: Yuki
authors.initials: Y
authors.lastname: Saito
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Suzuki
authors.forename: Takuho
authors.initials: T
authors.lastname: Okamura
authors.forename: Banri
authors.initials: B
authors.lastname: Tsuda
authors.forename: Mizuho
authors.initials: M
authors.lastname: Terada
authors.forename: Mayako
authors.initials: M
authors.lastname: Terao
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Tokuda
mesh_terms: D001943:Breast Neoplasms / Q000473:pathology / Q000517:prevention & control / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D055317:Evidence-Based Practice; D006801:Humans; D009367:Neoplasm Staging; D017410:Practice Guidelines as Topic